Detalles de la búsqueda
1.
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).
Ann Hematol
; 98(2): 361-367, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30353388
2.
Outcomes of hematopoietic stem cell transplantation from unmanipulated haploidentical versus matched sibling donor in patients with acute myeloid leukemia in first complete remission with intermediate or high-risk cytogenetics: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 103(8): 1317-1328, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29748438
3.
Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone.
Support Care Cancer
; 24(12): 4835-4837, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27726031
4.
A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide.
Clin Case Rep
; 5(4): 505-507, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28396778
Resultados
1 -
4
de 4
1
Próxima >
>>